RIO DE JANEIRO, BRAZIL - A consortium of Brazilian companies and foundations will donate R$100 (US$20) million to equip and finance a national Covid-19 vaccine factory. The vaccine to be produced will initially be that developed by Oxford University together with the British pharmaceutical laboratory AstraZeneca.
The partnership was closed between Ambev, Americanas, Itaú Unibanco, Stone, the Votorantim Institute, the Lemann Foundation, the Brava Foundation and the Behring Family Foundation.
The partnership will fund the production equipment and a quality control laboratory, which will be managed by the Oswaldo Cruz Foundation (Fiocruz). The group will invest in adjustments . . .